Kardigan, Inc.
KARD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002123613
No open-market purchases or sales by Kardigan, Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $1.37B in total; Soros Fund Management is the only superinvestor holding it.
Holders of 5% or more of KARD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kardigan, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Kardigan, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Kardigan, Inc., newest first.
No Schedule 13D or 13G filings on Kardigan, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Kardigan, Inc. shares.
No Form 144 notices for Kardigan, Inc. are on file.